Transparency

As a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Bristol Myers Squibb supports and complies fully with the EFPIA Disclosure Code for payments made to healthcare professionals (HCPs), Healthcare Organisations (HCOs) and Patient Organisations. Our collaboration with the healthcare community is an important and necessary aspect of bringing innovative medicines to patients and ensuring understanding of the safe and appropriate use of our medicines for the benefit of patients.

Transfer of value and data privacy

Health Professionals and Healthcare Organisations

As a member of the Irish Pharmaceutical Healthcare Association (IPHA), BMS is required to disclose certain details about transfers of value we make to HCPs in accordance with the IPHA Code of Practice. When disclosing amounts paid to healthcare professionals, we rely on our legitimate interests to use your personal data.

For further details about how we use our legitimate interest to disclose your personal data and your rights to privacy, you can access our BMS transparency privacy notice here.

For more information, please visit the Irish Pharmaceutical Health Association website.

Patient Organisations

To view the latest information on payments Bristol Myers Squibb has made to support the work of patient organisations, please click here . Information on payments made in 2022 are available here  and 2021 available here . For information on EFPIA - Patient Advocacy Group Methodology please click here.

NO-IE-2400069
Date of preparation: July 2024